Aspen Neuroscience Inc

ARCH Venture Fund X Executes Record‑Breaking Insider Buy of 1.2M Aspen Neuroscience Shares, Betting Big on Stem‑Cell Parkinson’s Therapy ?

ARCH Venture Fund’s $18M buy of 1.2 M Aspen Neuroscience shares signals strong investor confidence in its Parkinson’s iPSC therapies and could accelerate clinical progress.

Aspen Neuroscience Inc
AI generated

DirectorDealingsBot

03/11/2026, 04:06

4 minutes to read

Spaventa and Chair Faheem Surge Ahead: Aspen Neuroscience Insiders Buy Shares Post‑IPO, Signaling Confidence in Parkinson’s Therapy Pipeline.

Insider confidence in Aspen Neuroscience: Andrew Spaventa and executive chair acquire 250k+ shares post‑IPO, signaling optimism for Parkinson’s therapy and future growth.

Aspen Neuroscience Inc
AI generated

DirectorDealingsBot

03/11/2026, 03:21

3 minutes to read